Search Within

Marjorie G Zauderer

Formats
  1. Meeting Abstract (99)
  2. Journal Article (73)
  3. Editorial (9)
  4. Review (3)
  5. Book Section (2)
  6. Correspondence (2)
  7. Miscellaneous (1)
Groups
  1. Department of Medicine (189)
  2. Solid Tumor Oncology Division (189)
  3. Thoracic Oncology (189)
  4. Surgery (105)
  5. Department of Pathology and Laboratory Medicine (68)
  6. GSK Faculty (63)

More Groups

People
  1. Prasad Adusumilli (61)
  2. Valerie Rusch (61)
  3. Michael Offin (45)
  4. Marc Ladanyi (44)
  5. Jennifer Sauter (40)
  6. Andreas Rimner (38)

More People

Years
  1. 2025 (6)
  2. 2024 (17)
  3. 2023 (12)
  4. 2022 (21)
  5. 2021 (20)
  6. 2020 (13)

More Years

Publications
  1. Journal of Clinical Oncology (40)
  2. Journal of Thoracic Oncology (32)
  3. Modern Pathology (11)
  4. International Journal of Radiation Oncology, Biology, Physics (10)
  5. Clinical Cancer Research (7)
  6. Laboratory Investigation (7)

More Publications

Publishers
  1. Elsevier Inc. (50)
  2. American Society of Clinical Oncology (43)
  3. American Association for Cancer Research (18)
  4. Nature Publishing Group (11)
  5. Nature Research (11)
  6. Oxford University Press (8)

More Publishers

Results (189)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • COMMAND: A phase II randomized, double-blind, placebo-controlled, multicenter study of defactinib as maintenance therapy in subjects with malignant pleural mesothelioma that has not progressed on at least four cycles of pemetrexed/platinum therapy
    Meeting Abstract

    Fennell, D. A.; Baas, P.; Kindler, H. L.; Krug, L. M.; Nowak, A.; Zauderer, M.; Gralla, R. J.; Keegan, M.; Horobin, J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Next steps for IBM Watson Oncology: Scalability to additional malignancies
    Meeting Abstract

    Epstein, A. S.; Zauderer, M. G.; Gucalp, A.; Seidman, A. D.; Caroline, A.; Fu, J.; Keesing, J.; Hsiao, F.; Megerian, M.; Eggebraaten, T.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Failure patterns after hemithoracic pleural intensity modulated radiation therapy for malignant pleural mesothelioma
    Journal Article

    Rimner, A.; Spratt, D. E.; Zauderer, M. G.; Rosenzweig, K. E.; Wu, A. J.; Foster, A.; Yorke, E. D.; Adusumilli, P.; Rusch, V. W.; Krug, L. M.
    International Journal of Radiation Oncology, Biology, Physics (2014)

    Fulltext@MSK | Save
  • Trial of a 5-day dosing regimen of temozolomide in patients with relapsed small cell lung cancers with assessment of methylguanine-DNA methyltransferase
    Journal Article

    Zauderer, M. G.; Drilon, A.; Kadota, K.; Huberman, K.; Sima, C. S.; Bergagnini, I.; Sumner, D. K.; Travis, W. D.; Heguy, A.; Ginsberg, M. S.; more...
    Lung Cancer (2014)

    Fulltext@MSK | Save
  • A prospective study of tumor suppressor gene methylation as a prognostic biomarker in surgically resected stage i to IIIA non-small-cell lung cancers
    Journal Article

    Drilon, A.; Sugita, H.; Sima, C. S.; Zauderer, M.; Rudin, C. M.; Kris, M. G.; Rusch, V. W.; Azzoli, C. G.
    Journal of Thoracic Oncology (2014)

    Fulltext@MSK | Save
  • Vinorelbine and gemcitabine as second- or third-line therapy for malignant pleural mesothelioma
    Journal Article

    Zauderer, M. G.; Kass, S. L.; Woo, K.; Sima, C. S.; Ginsberg, M. S.; Krug, L. M.
    Lung Cancer (2014)

    Fulltext@MSK | Save
  • Beyond Jeopardy!: Harnessing IBM's Watson to improve oncology decision making
    Meeting Abstract

    Bach, P.; Zauderer, M. G.; Gucalp, A.; Epstein, A. S.; Norton, L.; Seidman, A. D.; Caroline, A.; Grigorenko, A.; Bartashnik, A.; Wagner, I.; more...
    Journal of Clinical Oncology (2013)

    Fulltext@MSK | Save
  • Defining BAP1 syndrome: Preliminary results from an epidemiologic ascertainment study
    Meeting Abstract

    Zauderer, M. G.; McMillan, R.; Sima, C. S.; Robson, M.; Rusch, V. W.; Krug, L. M.; Ladanyi, M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Lack of response to chemotherapy for previously treated malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Zauderer, M. G.; Kass, S. L.; Sima, C. S.; Ginsberg, M. S.; Krug, L. M.
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save
  • Safety of hemithoracic pleural intensity-modulated radiation therapy (IMRT) for malignant pleural mesothelioma (MPM) in the multimodality setting: Interim analysis of a phase II study
    Meeting Abstract

    Wu, A. J.; Zauderer, M. G.; Gomez, D.; Rosenzweig, K. E.; Foster, A.; Yorke, E.; Rice, D.; Tsao, A.; Rusch, V. W.; Krug, L. M.; more...
    Journal of Thoracic Oncology (2013)

    Fulltext@MSK | Save